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Abstract
To investigate the implications of altered sorting of the L-amyloid precursor protein (LAPP) in the abnormal generation of
amyloid L-protein (AL), we characterized AL secreted from Madin-Darby canine kidney (MDCK) cells which had been
stably transfected with a cDNA encoding the human L-amyloid precursor protein (LAPP695) with a 42 amino acid residue
truncation at the carboxyl terminus (vC). In vC MDCK cells, the intracellular sorting of LAPP is substantially altered to the
apical surface. We detected an accumulation of a unique AL species in the apical compartment of vC MDCK cell cultures.
This unique AL was immunoprecipitated with 4G8 (a monoclonal antibody specific for AL17^24) and detected as a smear on
Western blots, but was not immunoprecipitated with BAN50 (a monoclonal antibody raised against AL1^16). Interestingly,
however, this AL species was readily immunoprecipitated with BAN50 upon treatment with formic acid. Furthermore,
incubation of the vC MDCK cells with compactin, an inhibitor of de novo cholesterol synthesis, or with filipin, a cholesterol-
binding drug, resulted in marked changes in the characteristics of this AL species as follows: first, the AL was not observed as
a smear on Western blots and second, the AL was immunoprecipitated with BAN50. The present results strongly suggest that
an AL with unique molecular characteristics is generated from the missorted LAPP in vivo in a cholesterol-dependent
manner. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The abnormal accumulation of amyloid L-protein
(AL), a proteolytic cleavage product of L-amyloid
precursor protein (LAPP), a large membrane-span-
ning glycoprotein [1], is an invariable neuropatholog-
ical feature of Alzheimer’s disease (AD). Several lines
of evidence indicate that abnormal generation of AL
due to altered processing of LAPP is a fundamental
step in the development of AD. The cellular mecha-
nisms underlying the generation and secretion of AL
are still far from achieving a complete understanding,
although previous studies have revealed that AL is
generated in acidic intracellular organelles such as
endosomes following internalization of LAPP [2,3]
and/or in the endoplasmic reticulum [4]. It is known
that AL is cleaved from LAPP at the amino and
carboxyl termini of AL by L- and Q-secretases, respec-
tively (AL-generating pathway). LAPP is also cleaved
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by K-secretase within the AL sequence, liberating the
soluble derivative of LAPP (APPs) (APPs-secreting
pathway). In the latter case, the generation of AL
is precluded. Previous studies have demonstrated
that the activation of protein kinase C causes a shift
from the AL-generating pathway to the APPs-secret-
ing pathway (for review, see [5]). It was recently re-
ported that intracellular and secreted AL species are
generated via distinct LAPP processing pathways [6].
Thus, intracellular sorting of LAPP is likely to be one
of the factors determining the generation of AL.
The aim of this study was to investigate the role of
altered sorting of LAPP in the abnormal generation
of AL. We characterized the AL secreted from Mad-
in-Darby canine kidney (MDCK) cells which have
been extensively studied in terms of cell polarity [7].
It is known that, in MDCK cells, LAPP undergoes
highly polarized sorting principally to the basolateral
surface [8]. As previously reported [8,9], the majority
of AL is basolaterally secreted from MDCK cells.
We extended this line of experimentation to the study
of MDCK cells which had been transfected with
LAPP cDNA encoding a 42 amino acid carboxyl-
terminal truncated LAPP (vC MDCK cells), in
which the intracellular sorting of LAPP is substan-
tially altered to the apical surface [9].
Recently, much attention has been focused on the
physiological roles of cholesterol and glycosphingo-
lipids which form speci¢c lipid microdomains des-
tined for the apical surfaces of epithelial cells (for
review, see [10]). Regarding the pathological implica-
tions of these lipid microdomains, it is noteworthy
that such microdomains in neurons (caveolae-like
domains, CLDs) are likely to be the site of conver-
sion of a normal cellular form (PrPc) of prion protein
to a pathological, amyloidogenic scrapie form (PrPsc)
with a high proportion of L-sheet structures, which
causes fatal neurodegenerative diseases [11,12]; chol-
esterol depletion inhibits the formation of the scrapie
form [11]. Thus, it is intriguing to investigate the
molecular characteristics of AL which is generated
in membranes containing abundant cholesterol and
glycosphingolipids. An advantage of using vC
MDCK cells is that we could determine the e¡ect
of the cholesterol and/or glycosphingolipid which
are abundant in the apical membranes [13,14], on
the generation of AL.
In this study, we detected a unique form of AL
species in the medium of the apical compartment
of the vC MDCK cell cultures. The most striking
result that emerges from this study is that the gen-
eration of this unique AL is dependent on the level of
intracellular cholesterol. These results may provide a
new insight into the pathological implications of the
altered sorting of LAPP in the abnormal generation
of AL in the brains of patients with AD.
2. Material and methods
2.1. MDCK cell culture
MDCK cells were cultured as previously described
[8,9,15]. Dulbecco’s modi¢ed Eagle’s medium (Gib-
co, BRL) supplemented with 10% fetal bovine serum
(FBS) was used as the culture medium. We plated
2.5^3.0U105 MDCK cells transfected with human
LAPP695 cDNA onto 24 mm Transwell ¢lters (Co-
star) and then cultured these cells on the ¢lters for
3 days. To determine the integrity of the cell mono-
layers that grew on the ¢lters, measurement of the
electrical resistance between apical and basolateral
compartments of the MDCK cell cultures was per-
formed by immersing electrodes in each compart-
ment (according to a protocol provided by World
Precision Instruments). Complete integrity of the
cell monolayers was con¢rmed by the absence of
the leakage of AL which had been added to the baso-
lateral compartment, into the apical compartment.
The media of the MDCK cell cultures were changed
3 days after plating, and the cells were then cultured
for a further 24 h. Finally, the media in both com-
partments were collected for immunochemical analy-
sis. The procedures for synthesis and transfection of
LAPP cDNA were as previously described [8,9].
Brie£y, cDNA encoding the full-length and 42 amino
acid carboxyl-terminal truncated forms of human
LAPP695 were generated by PCR using an oligonu-
cleotide designed to introduce stop codons at the
corresponding positions. Stable transfection of
MDCK cells and the selection of single cell clones
were performed as previously described [8].
2.2. Antibodies
The anti-AL monoclonal antibodies used in this
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study were BAN50 (raised against AL1^16), BA27
(speci¢c for AL40), BC05 (speci¢c for AL42 or
AL43) and 4G8 (speci¢c for AL17^24), whose char-
acteristics have been previously described [16^18].
2.3. Enzyme immunoassay
The two-site enzyme immunoassay (EIA) for AL
was performed essentially as previously described
[16,17]. Brie£y, 100 Wl of the media of the apical
and basolateral compartments of the MDCK cell
cultures were diluted with 400 Wl of bu¡er EC (20
mM phosphate bu¡er (pH 7.0), 0.4 M NaCl, 2 mM
EDTA, 10% Block Ace (Dai-nippon, Tokyo, Japan),
0.2% bovine serum albumin and 0.05% NaN3), and
100 Wl of the mixture were subjected to the two-site
EIA. The BAN50 and 4G8, used as capture antibod-
ies, were coated onto multiwell plates, and BC05 and
BA27 were used as detector antibodies following
their conjugation with horseradish peroxidase. An
appropriate amount of synthetic AL40 or AL42
(Bachem California, CA, USA), was applied, for
the construction of a standard curve, to a BAN50-
coated multiwell plate which was incubated at 4‡C
overnight. After rinsing with phosphate-bu¡ered sal-
ine (PBS), loaded wells were reacted with appropri-
ately diluted horseradish peroxidase-conjugated
BA27 or BC05 at 4‡C overnight. Bound enzyme ac-
tivities were measured using the TMB Microwell Per-
oxidase Substrate System (Kirkegaard and Perry
Labs., Gaithersburg, MD, USA).
2.4. Immunoprecipitation and Western blotting
Aliquots (1.5 ml) of the media from the cultures of
transfected MDCK cells, 24 h after reaching com-
plete integrity of the cell monolayer, were incubated
with BAN50 (5.8 Wg) at 4‡C overnight for AL detec-
tion. The mixtures were then incubated with protein
G Sepharose at 4‡C for 3 h, and centrifuged. In the
experiments for AL detection, the resultant superna-
tants were subsequently incubated with 4G8 (1.5 Wg)
at 4‡C overnight. The pellets were washed thor-
oughly with Tris-saline bu¡er, and subjected to pro-
tein solubilization by boiling in Laemmli bu¡er con-
taining 8 M urea for 5 min. The solubilized proteins
were separated on 4^20% gradient Tris-tricine SDS-
polyacrylamide gels (Multigel 4/20, Daiichi Chemi-
cal, Japan). Western blotting was performed accord-
ing to the method of Ida et al. [19]. Brie£y, the pro-
teins were transferred onto a 0.22 Wm nitrocellulose
membrane (Micron Separation, MA, USA) at 380
mA for 45 min using a semi-dry blotting apparatus;
the blots were heated in boiling PBS (8.1 mM diso-
dium hydrogen phosphate, 1.5 mM potassium dihy-
drogen phosphate, 137 mM sodium chloride, and 2.7
mM potassium chloride, pH 7.4) for 5 min, and then
blocked with 5% skim milk in PBS containing 0.05%
Tween 20 (PBS-T) for 30 min at room temperature
(RT). After rinsing, the blots were incubated with
BA27 (1 Wg/ml) for AL detection. The antibodies
were diluted with 0.025% bovine serum albumin
(BSA)-containing PBS-T. The blots were washed
4 times at RT with PBS-T, and then incubated
with horseradish peroxidase-conjugated anti-mouse
IgG (Gibco, BRL) as a secondary antibody, diluted
with 0.025% BSA-containing PBS-T, at 4‡C over-
night. The blots were again washed as described
above, and the bound-enzyme activities were visual-
ized using an enhanced chemiluminescence (ECL)
detection system (Amersham, Buckinghamshire,
UK).
2.5. Formic acid treatment
The 4G8 immunoprecipitates from 1.5 ml aliquots
of the media from the apical and basolateral com-
partments of the vC MDCK cell cultures were incu-
bated in 200 Wl of highly concentrated formic acid at
RT for 30 min. The mixtures were then centrifuged
at 15 000Ug for 15 min. The supernatants were vac-
uum-dried, and the residual pellets solubilized by
boiling for 5 min in 25 Wl of Laemmli bu¡er contain-
ing 8 M urea. The solubilized AL was diluted with
975 Wl of Tris-saline bu¡er, and incubated with
BAN50 (3.8 Wg/ml) at 4‡C overnight for reimmuno-
precipitation. Western blotting was performed as de-
scribed above.
2.6. Inhibition of de novo cholesterol synthesis
To inhibit de novo cholesterol synthesis, MDCK
cells were incubated for 2 h with compactin (Sigma),
a potent competitive inhibitor of 3-hydroxy-3-meth-
ylglutaryl-coenzyme A reductase activity at concen-
trations ranging from 100 nM to 5000 nM and then
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exposed to 2 WCi of [14C]acetate. After a further 2 h,
all cells were harvested, and the concentration of
newly synthesized cholesterol was quantitated by de-
termining the amount of radioactivity incorporated
into free cholesterol separated by thin layer chroma-
tography, using a Bio-imaging Analyzer System-2500
Mac (Fuji Photo Film, Japan). To investigate the
e¡ect of the inhibition of de novo cholesterol syn-
thesis on the secretion of AL, vC MDCK cells
were pretreated with compactin for 90 min before
the media were changed to fresh ones. The cells
were cultured for a further 3 days with compactin,
and then 1.5 ml aliquots of the media from the apical
and basolateral compartments of the culture were
immunoprecipitated as described above.
2.7. Treatment with ¢lipin
MDCK cells were cultured in media containing
¢lipin (Sigma), a polyene antibiotic which speci¢cally
binds to cholesterol, at concentrations of 0.1 Wg/ml
and 0.3 Wg/ml for 90 min before the media were
changed to fresh ones. The cells were cultured for a
further 3 days with ¢lipin, and then 1.5 ml aliquots
of the media from the apical and basolateral com-
partments of the culture were immunoprecipitated as
described above.
2.8. Densitoscanning and statistical analysis
The intensity of the bands corresponding to AL
was determined densitometrically. The relative inten-
sity values of the AL detected in the medium of ap-
ical compartment to those of the AL in the medium
of basolateral compartment were statistically ana-
lyzed using Student’s t-test.
3. Results
3.1. MDCK cell culture system
The MDCK cells (2.5^3.0U105) were plated onto
a 24 mm Transwell ¢lter and then cultured for 3 days.
The growth of the cells was indirectly monitored by
phase-contrast microscopic observation of a sister
culture plated onto a 35 mm culture dish at the
same cell density. The cultured cells appeared con-
£uent at 48 h after plating, and the electrical resist-
ance between the apical and the basolateral compart-
ments decreased slightly following a peak at 48 h,
and then reached a plateau (Fig. 1). For con¢rma-
tion of the integrity of the cell monolayer, the
amount of the leaked AL was determined by EIA;
no AL leakage was detected at 72 h after plating
(Fig. 1).
3.2. Polarized secretion of AL from wild-type and
vC MDCK cells
To investigate the polarized secretion of AL from
vC MDCK cells, we employed a procedure of im-
munoprecipitation of AL with BAN50. Blots of the
immunoprecipitates were reacted with BA27. We de-
tected the polarized secretion of AL40 from the vC
MDCK cells predominantly into the basolateral
compartment, essentially as for the case of the
Fig. 1. Measurement of transmembrane electrical resistance,
and the percentage of AL leaked in MDCK cell cultures.
MDCK cells transfected with human LAPP695 cDNA were
grown in Dulbecco’s modi¢ed Eagle’s medium supplemented
with 10% FBS. The grown cells were replated at semi-con£uent
density onto 24 mm Transwell ¢lters (Costar) (2.5^3.0U105
cells/well). The cells on the ¢lters were then incubated with 1.5
ml of medium in the apical compartment, 2.5 ml in the basolat-
eral compartment, and grown for a further 3 days. Transmem-
brane electrical resistance was measured with a device (EVOM)
from World Precision Instruments. Synthetic AL (500 fmol of
AL40 or AL42) was added to the basolateral compartment. The
levels of AL which leaked into the apical compartment from
the basolateral compartment were determined by EIA as de-
scribed in Section 2. BAN50-coated multiwell plates were used.
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wild-type MDCK cells (Fig. 2a). These results
strongly suggest that a fraction of AL40 molecules
is generated intracellularly, before LAPP is sorted
to the cell surface. Regarding the generation of AL
from the apically transported LAPP in the vC
MDCK cells, we considered the possibility that ami-
no-terminal truncated AL, which is not recognized by
BAN50, was secreted. To test this possibility, the
monoclonal antibody 4G8 was used for the subse-
quent immunoprecipitation of AL in the medium
from the apical compartment of vC MDCK cell cul-
tures, which had been preincubated with BAN50. We
detected strong BA27 immunoreactivity in the me-
dium of the apical compartment of vC MDCK cell
cultures on a Western blot (Fig. 2b). Interestingly,
the AL was detected as a smear on the blot, and its
electrophoretic mobility was lower than that of AL
secreted into the basolateral compartment of the
wild-type and the vC MDCK cell cultures (Fig. 2b).
3.3. Incubation of synthetic AL in the media of
MDCK cells
To investigate whether the unique molecular char-
acteristics of the AL, including its appearance as a
smear and its retarded mobility in SDS-polyacryl-
amide gel electrophoresis, are caused by the presence
of lipids coprecipitated from the media, we per-
formed immunoprecipitation of synthetic AL1^40
which had been incubated in the media of the apical
and basolateral compartments of non-transfected
MDCK cells. As shown in Fig. 3, smearing of the
AL was not observed on the blots. Thus, it appears
likely that the unique AL in the media of the apical
compartment of vC MDCK cells is generated prior
to its secretion.
Fig. 3. Western blot of immunoprecipitated synthetic AL1^40,
which had been incubated in the media of the apical (A) or ba-
solateral (B) compartments of non-transfected MDCK cells, or
in fresh media (C). Two hundred pg of synthetic AL1^40 were
incubated in the media for 24 h and immunoprecipitated with
4G8. The blot of the immunoprecipitates was reacted with
BA27.
Fig. 2. Polarized secretion of AL40 from MDCK cells trans-
fected with human LAPP695 cDNA. (a) Immunoprecipitation
of AL40 secreted into the media of the apical and basolateral
compartments with BAN50 (a monoclonal antibody raised
against AL1^16). (b) Subsequent immunoprecipitation of AL40
in the media which had been preincubated with BAN50, with
4G8 (a monoclonal antibody speci¢c for AL17^24). The blots
of the immunoprecipitates were reacted with BA27 (a monoclo-
nal antibody speci¢c for AL40). Wild-type and vC indicate the
MDCK cells transfected with cDNA encoding the full-length
and carboxyl-terminal truncated human LAPP, respectively. (A)
apical compartment; (B) basolateral compartment.
Fig. 4. Characterization of AL in the apical compartment of
vC MDCK cells. The AL immunoprecipitated with 4G8, in the
apical compartment of vC MDCK cells, was analyzed by West-
ern blotting using various anti-AL monoclonal antibodies. Note
that the AL was recognized by BAN50, which was raised
against AL1^16, and that both AL40 and AL42 in the apical
compartments appear as a smear on immunoblotting.
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3.4. Characterization of AL immunoprecipitated with
4G8
To characterize the AL which is immunoprecipi-
tated with 4G8 from the medium in the apical com-
partment of vC MDCK cell cultures, the immuno-
precipitated AL was analyzed by Western blotting
using various anti-AL monoclonal antibodies. On
the blot, the AL reacted with BAN50 (Fig. 4), ex-
cluding the possibility that the AL is p3 (a major
amino-terminally truncated form of AL), since
BAN50 was raised against AL1^16. The AL also re-
acted with BC05 and appeared as a smear, as it did
with BA27, although the density of the band was
weaker than that observed upon reaction with
BA27 (Fig. 4). These results indicate that the species
of AL imunoprecipitated with 4G8 in the apical com-
partment of vC MDCK cell cultures are likely to be
AL1^40 and AL1^42.
3.5. E¡ect of formic acid treatment on the BAN50
immunoprecipitation of AL secreted into the
apical compartment of vC MDCK cell cultures
Based on the results shown in Fig. 2, we specu-
lated that the AL secreted into the apical compart-
ment of the vC MDCK cell cultures was not recog-
nized by BAN50 due to its altered immunoreactivity
although this AL has the full amino acid sequence of
AL1^40. To test this possibility, we treated the 4G8
immunoprecipitates from the media of the apical and
basolateral compartments of vC MDCK cell cultures
with concentrated formic acid to restore normal AL
immunoreactivity from the one which the peptide
had adopted. Immunoprecipitation with BAN50 sub-
sequent to this treatment resulted in a substantial
increase in AL immunoreactivity on the Western
blotting of the proteins from the medium of the ap-
ical compartment of vC MDCK cell cultures. The
intensity of the immunoreactivity of the apical AL
was comparable to that of the basolateral AL (Fig.
5).
3.6. E¡ect of inhibition of de novo cholesterol
synthesis on the secretion of the AL from
the apical surface of vC MDCK cells
Regarding the molecular mechanism of the gener-
ation of this unique AL species, we considered the
possibility that the AL was generated via interaction
with cholesterol and/or glycosphingolipids since these
lipids are abundant in apical surface membrane and
apically transported vesicles [10]. To examine this
possibility, we ¢rst inhibited cholesterol synthesis us-
ing compactin. The optimum concentration of com-
pactin for use in our experiments was determined as
follows. The MDCK cells were treated with compac-
tin at concentrations in a range from 100 nM to 5000
nM. The de novo cholesterol synthesis was decreased
to approx. 40% of the control level by compactin at
concentrations ranging from 500 nM to 1000 nM
(Fig. 6a). The treatment of the cells with compactin
at a concentration of 5000 nM caused marked cell
death (data not shown). To investigate the role of
cholesterol in the generation of this unique AL, vC
MDCK cells were treated with compactin at concen-
trations of 500 nM and 1000 nM for 3 days. Incu-
bation of the cells with compactin at the concentra-
tions indicated above did not a¡ect the cell viability,
which was assayed using the calsein AM/ethidium
homodimer staining kit (Molecular Probes, OR,
USA) (data not shown). To exclude the possibility
that treatment with compactin causes a change in the
amount of AL secreted, the levels of secreted AL to
the apical and basolateral compartments were deter-
Fig. 5. E¡ect of formic acid treatment on AL immunoprecipita-
tion with BAN50. The amount of AL which was reimmunopre-
cipitated with BAN50 in the apical compartment following 4G8
immunoprecipitation was increased to a level comparable to
that in the basolateral compartment following formic acid treat-
ment. (1)IP, ¢rst immunoprecipitation; (2)IP, reimmunoprecipi-
tation of the ¢rst immunoprecipitates following solubilization in
Laemmli sample bu¡er; FA, formic acid treatment.
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mined using EIA. As shown in Fig. 6b, the amount
of AL secreted to the apical and basolateral compart-
ments was not altered following the treatment with
compactin. However, interestingly, the AL immuno-
precipitated with 4G8 from the medium of the apical
compartment of vC MDCK cells which were treated
with compactin was not detected as a smear on the
Western blots (Fig. 6c). This e¡ect of compactin on
the disappearance of a smear on the blot was dose
dependent. Furthermore, treatment of the cells with
compactin increased the amount of AL species (AL40
and AL42) which were immunoprecipitated with
BAN50 in the apical compartment of vC MDCK
cell cultures (Fig. 7). The increase in the densities
of the bands corresponding to AL were statistically
signi¢cant (AL40: P6 0.01; AL42: P6 0.01).
3.7. E¡ect of cholesterol binding on the secretion
of the AL from the apical surface of
vC MDCK cells
To further con¢rm the involvement of cholesterol
in the generation of the unique AL, vC MDCK cells
were treated with ¢lipin, a cholesterol-binding drug,
at concentrations of 0.1 Wg/ml and 0.3 Wg/ml, for
3 days. As shown in Fig. 8, the AL secreted from
the apical surface of vC MDCK cells ceased to ap-
pear as a smear on the blot in a dose-dependent
manner. In contrast, the treatment with ¢lipin did
not cause any alterations in the appearance of AL
secreted from basolateral surface (Fig. 8).
C
Fig. 6. E¡ects of inhibition of de novo cholesterol synthesis on
the secretion of the AL from the apical surface of vC MDCK
cells. (a) Inhibition of de novo cholesterol synthesis by compac-
tin. The MDCK cells were cultured in media containing com-
pactin at concentrations ranging from 100 nM to 5000 nM for
2 h at 37‡C, and then exposed to 2 WCi of [14C]acetate for a
further 2 h. The incorporation of [14C]acetate into newly syn-
thesized cholesterol was determined by quantitating the radioac-
tivity on thin layer chromatography plates using a Bio-imaging
Analyzer System-2500 Mac. (b) Polarized secretion of AL40
from vC MDCK cells treated with compactin at the concentra-
tions indicated. The two-site EIA was performed as described
in Section 2. 4G8-coated multiwell plates were used. Note that
the treatment of cells with compactin did not cause an altera-
tion in the amount of AL40 secreted. Each column indicates
the average of ¢ve values. (c) E¡ect of compactin on the ap-
pearance of the AL on the blots. The MDCK cells were cul-
tured in the media containing compactin at concentrations of
500 nM or 1000 nM for 3 days. The AL in the apical (A) and
basolateral (B) compartments were immunoprecipitated with
4G8. The blots of the immunoprecipitates were reacted with
BA27. Note that the disappearance of the smear on the blots
of AL from the apical compartment occurred in a dose-depend-
ent manner, whereas there was no change in the appearance on
the blots of AL from the basolateral compartment.
BBAMEM 77416 1-8-98
T. Mizuno et al. / Biochimica et Biophysica Acta 1373 (1998) 119^130 125
4. Discussion
We are still far from achieving complete under-
standing of the molecular mechanism of physiologi-
cal and pathological generation of AL. In this regard,
we, here, present the following hypothetical model
based on the results of this study (Fig. 9). A scenario
is thus envisaged wherein AL is generated at two
distinct sites, one before LAPP is sorted to the cell
surface and the other on the cell surface through
Fig. 7. E¡ect of inhibition of de novo cholesterol synthesis on the immunoprecipitation with BAN50. (a) The AL in the media was
immunoprecipitated with BAN50, and the blot reacted with BA27 and BC05. Note that the intensities of both AL40 and AL42 in the
apical compartment were increased by the treatment of cells with compactin, whereas there was no remarkable change in the inten-
sities of the ALs in the basolateral compartment. (b) The increase of the densities of the bands corresponding to the ALs were statisti-
cally analyzed. The relative intensities of the AL (AL40 and AL42) detected in the medium of the apical compartment compared to
those in the medium of the basolateral compartment were signi¢cantly increased upon treatment with compactin. Each column repre-
sents the average value obtained from ¢ve independent experiments. *P6 0.01(AL40); *P6 0.01(AL42).
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internalization of LAPP. We are also the ¢rst, to our
knowledge, to suggest the possibility that missorted
LAPP is processed to generate an AL with unique
molecular characteristics.
At this point, it is extremely di⁄cult to elucidate
the molecular mechanism of generation of this
unique AL ; however, it may be possible to assume
the following. In vC MDCK cells, LAPP molecules
may be inserted into apical transport vesicles [20],
unique lipid microdomains called rafts (for review
see [10]), which share the characteristic of a high
cholesterol and glycosphingolipid content with cav-
eolae or CLDs, and processed to generate the unique
AL. This hypothesis is supported by a previous ¢nd-
ing that some LAPP molecules in neurons are trans-
ported through axonal CLDs [21], which are analo-
gous to apical transport vesicles or rafts in epithelial
cells, although a report disputing LAPP localization
in CLDs has also been published [22]. In the case of
the wild-type MDCK cells, small amounts of LAPP
molecules may be inserted into the microdomains,
but the generation of the unique AL is likely to be
precluded through the internalization of LAPP from
the cell surface. Since vC LAPP is not internalized
due to the lack of a cytoplasmic domain [3,9], it
might be correct to state that not only missorting
of LAPP, but also impairment of its internalization
are prerequisites for the generation of the unique AL.
In vC MDCK cells, the AL generated from the mis-
Fig. 8. E¡ect of cholesterol binding on the appearance of the
AL secreted from vC MDCK cells on the blots. The vC
MDCK cells were cultured in media containing ¢lipin at con-
centrations of 0.1 Wg/ml and 0.3 Wg/ml for 3 days. The AL in
the media was immunoprecipitated with 4G8 and the blot of
the immunoprecipitates reacted with BA27. Note that the disap-
pearance of the smear on the blots of AL from the apical com-
partment (A) occurred in a dose-dependent manner, whereas
there was no change in the appearance of AL in the basolateral
compartment (B).
Fig. 9. A hypothetical model of the mechanism of AL generation. AL is generated at two distinct sites, one prior to and the other fol-
lowing sorting LAPP to the cell surface. In the latter case, the AL generation likely occurs through internalization of LAPP. The intra-
cellular site of AL generation may be in the ER or the Golgi, since mutations of presenilin, which encodes a protein localized in the
ER, cause abnormal generation of AL. In this study, conformationally altered AL was accumulated in the apical compartment where-
as no such conformationally altered AL was detected in the basolateral chamber, indicating that an apical surface-destined microdo-
main comprised of lipid molecules including cholesterol and glycosphingolipids is a prerequisite for the generation of AL with an al-
tered conformation.
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sorted LAPP apparently acquires unique molecular
characteristics including loss of BAN50 reactivity
and appearance as a smear on immunoblotting,
through interaction with some other elements local-
ized in the lipid microdomains. The possibility of
conversion of a constitutive protein to an abnormal,
pathogenic form in such lipid microdomains is
strongly supported by the report of the generation
of PrPsc from PrPc in CLDs [11,12].
One of the most likely explanations for the loss of
BAN50 reactivity is an association of the AL with
other molecules, since this hypothesis would be con-
sistent with the e¡ect of formic acid treatment (Fig.
5), which strips o¡ any binding protein or lipid mol-
ecules. We ¢rst considered the possibility of its asso-
ciation with GM1 ganglioside based on our previous
¢ndings [23,24]; however, we did not ¢nd any reac-
tivity for GM1 ganglioside on the AL blots (data not
shown). An association with other molecules is still
possible. We may also have to pay attention to the
possibility of the AL undergoing some unde¢ned
conformational transition since AL readily adopts
altered secondary structures depending on the con-
ditions of the environment [25^29] and association
with lipid molecules [30]. If we hypothesize that the
AL adopts an altered secondary structure, it would
be of great interest to determine, in future studies,
whether this novel AL is pathogenic since the amy-
loidogenic properties of AL are closely related to its
secondary structure [31,32].
Some surprising results noted in this study are the
e¡ects of cholesterol depletion on the appearance of
the unique molecular characteristics of the novel AL.
Previous reports of caveolae disappearing in choles-
terol-depleted cells [33], and of cholesterol depletion
inhibiting the conversion of PrPc to PrPsc [11], taken
together with the results of this study (Figs. 6^8),
make it likely that the microdomains, with a high
content of cholesterol, are the sites of generation of
this unique AL. In regard to the pathological role of
cholesterol in the development of AD, it is of partic-
ular interest that apolipoprotein E, the O4 genotype
of which is a major risk factor for the development
of AD [34^36], is closely associated with cholesterol
transport. In regard to the processing of LAPP, it
was recently reported that this was modulated by a
change in the cellular content of cholesterol [37,38].
Furthermore, alteration of cholesterol concentration
in AD brains has also been reported previously [39].
Taken together with the results of this study, LAPP
missorted to the cholesterol-rich cellular compart-
ment may play a role in the pathogenesis of AD.
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